Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-26

Clinical Trial Update: LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether combining LT4 and LT3 is more effective than LT4 alone in autoimmune hypothyroidism and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)
  • Liothyronine (liothyronine)

Snippet

Sponsor: M. Medici | Conditions: Autoimmune Hypothyroidism | Phase 3 | Status: RECRUITING